Browse Items (2 total)

• 

  Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

  Tags 2019-nCoV, Coronavirus, COVID-19, Outcomes, R-Res&Pub, Vaccine Study
  Creator: the mRNA-1273 Study Group
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2021-04-06
  Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19).
• 

  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

  Tags 2019-nCoV, Coronavirus, COVID-19, R-Res&Pub, Vaccine Study
  Creator: the mRNA-1273 Study Group
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2020-07-14
  Description: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion…